Abstract:Neurodegenerative diseases (NDs) such as Alzheimer's Disease (AD) and Parkinson's Disease (PD) are devastating conditions that can develop without noticeable symptoms, causing irreversible damage to neurons before any signs become clinically evident. NDs are a major cause of disability and mortality worldwide. Currently, there are no cures or treatments to halt their progression. Therefore, the development of early detection methods is urgently needed to delay neuronal loss as soon as possible. Despite advancements in Medtech, the early diagnosis of NDs remains a challenge at the intersection of medical, IT, and regulatory fields. Thus, this review explores "digital biomarkers" (tools designed for remote neurocognitive data collection and AI analysis) as a potential solution. The review summarizes that recent studies combining AI with digital biomarkers suggest the possibility of identifying pre-symptomatic indicators of NDs. For instance, research utilizing convolutional neural networks for eye tracking has achieved significant diagnostic accuracies. ROC-AUC scores reached up to 0.88, indicating high model performance in differentiating between PD patients and healthy controls. Similarly, advancements in facial expression analysis through tools have demonstrated significant potential in detecting emotional changes in ND patients, with some models reaching an accuracy of 0.89 and a precision of 0.85. This review follows a structured approach to article selection, starting with a comprehensive database search and culminating in a rigorous quality assessment and meaning for NDs of the different methods. The process is visualized in 10 tables with 54 parameters describing different approaches and their consequences for understanding various mechanisms in ND changes. However, these methods also face challenges related to data accuracy and privacy concerns. To address these issues, this review proposes strategies that emphasize the need for rigorous validation and rapid integration into clinical practice. Such integration could transform ND diagnostics, making early detection tools more cost-effective and globally accessible. In conclusion, this review underscores the urgent need to incorporate validated digital health tools into mainstream medical practice. This integration could indicate a new era in the early diagnosis of neurodegenerative diseases, potentially altering the trajectory of these conditions for millions worldwide. Thus, by highlighting specific and statistically significant findings, this review demonstrates the current progress in this field and the potential impact of these advancements on the global management of NDs.

Applications of machine learning to diagnosis and treatment of neurodegenerative diseases

Navigating the Frontiers of Machine Learning in Neurodegenerative Disease Therapeutics

Leveraging Computational Intelligence Techniques for Diagnosing Degenerative Nerve Diseases: A Comprehensive Review, Open Challenges, and Future Research Directions

Machine learning as a new tool in neurological disease prevention, diagnosis, and treatment

Artificial Intelligence in The Management of Neurodegenerative Disorders

Neuroimaging and Machine Learning for Dementia Diagnosis: Recent Advancements and Future Prospects.

Applications and Challenges of Machine Learning Methods in Alzheimer's Disease Multi-Source Data Analysis

Advances in Computational Biology for Diagnosing Neurodegenerative Diseases: A Comprehensive Review

A Comprehensive Review of the Application of Machine Learning in Medicine and Health Care

Machine learning applications on neuroimaging for diagnosis and prognosis of epilepsy: A review

Machine learning approaches for neurological disease prediction: A systematic review

The Emerging Role of Long Non-Coding RNAs and MicroRNAs in Neurodegenerative Diseases: A Perspective of Machine Learning

Review of Deep Learning Techniques for Neurological Disorders Detection

Data science in neurodegenerative disease: its capabilities, limitations, and perspectives

Machine learning applications in stroke medicine: advancements, challenges, and future prospectives

Machine Learning and Digital Biomarkers Can Detect Early Stages of Neurodegenerative Diseases

Machine learning models for diagnosis and prognosis of Parkinson's disease using brain imaging: general overview, main challenges, and future directions

Applied machine learning in Alzheimer's disease research: omics, imaging, and clinical data

Machine learning based algorithms for virtual early detection and screening of neurodegenerative and neurocognitive disorders: a systematic-review

Alzheimers Disease Diagnosis using Machine Learning: A Review

Artificial Intelligence-Based Methodologies for Early Diagnostic Precision and Personalized Therapeutic Strategies in Neuro-Ophthalmic and Neurodegenerative Pathologies